“Precision” drug development?

descriptionPublicationkeyboard_double_arrow_right Article 20 Nov 2015 English Publisher:WileyJournal:Clinical Pharmacology & Therapeutics, volume 99, pages 152-154 (issn: 0009-9236, eissn: 1532-6535,

Copyright policy )

Authors: J, Woodcock;

doi: 10.1002/cpt.255

pmid: 26331240

“Precision” drug development?

- Summary
- Subjects
- Metrics

Abstract

The concept of precision medicine has entered broad public consciousness, spurred by a string of targeted drug approvals, highlighted by the availability of personal gene sequences, and accompanied by some remarkable claims about the future of medicine. It is likely that precision medicines will require precision drug development programs. What might such programs look like?

Related Organizations

United States Food and Drug Administration
United States
Center for Drug Evaluation and Research
United States

Keywords

United States Food and Drug Administration, Drug Design, Drug Discovery, Pharmacology, Clinical, Humans, Precision Medicine, Drug Approval, United States

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	10
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%